Supportive care measures are an important aspect of the treatment of myeloma because they address the symptoms and complications of the disease.

Supportive therapies commonly used in myeloma include:

• Bisphosphonates, such as Aredia®, Zometa®, and others, which help reduce the advancement of bone disease, decrease bone pain, and reduce fractures
• Growth factors, which help the bone marrow produce more red and white blood cells
• Antibiotics, which help treat and prevent infection
• Orthopedic interventions, which help control pain and improve functioning and mobility
• Pain control measures, such as medication, radiation, and radiopharmaceuticals such as Quadramet®